PHASE-II EVALUATION OF MITOXANTRONE PLUS CISPLATINUM IN PATIENTS WITH ADVANCED BREAST-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY

被引：5
作者：
ATIBA, JO
GREEN, SJ
HYNES, HE
OSBORNE, CK
MILLER, TP
DAVIDNER, M
机构：
[1] UNIV CALIF IRVINE,COLL MED,IRVINE,CA 92717
[2] SW ONCOL GRP,CTR STAT,SEATTLE,WA
[3] WICHITA CCOP,WICHITA,KS
[4] UNIV TEXAS,HLTH SCI CTR,SAN ANTONIO,TX
[5] UNIV ARIZONA,ARIZONA CANC CTR,TUCSON,AZ 85724
[6] KANSAS CITY CLIN ONCOL PROGRAM,KANSAS CITY,MO
来源：
INVESTIGATIONAL NEW DRUGS | 1994年 / 12卷 / 02期
关键词：
CISPLATINUM; MITOXANTRONE; BREAST CANCER; PHASE I-II TRIAL;
D O I：
10.1007/BF00874442
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The Southwest Oncology Group studied the response rate and toxicity of mitoxantrone (7.5 or 10 mg/m(2) to 12.0 mg/m(2)) and cis-platinum (100 mg/m(2)) in 30 patients with advanced breast cancer as second-line therapy. There were 2 partial responses in 29 eligible patients. Toxicity was considerable, with 27 patients having grade 3 or 4 toxicity. Grade 3-4 toxicity included vomiting, thrombocytopenia, granulocytopenia, leukopenia and anemia. The combination of mitoxantrone plus cis-platinum has minimal activity as second-line therapy in metastatic breast cancer.
引用
收藏
页码：129 / 132
页数：4
相关论文
共 50 条
[31]   Phase I/II study of gemcitabine plus mitoxantrone as salvage chemotherapy in metastatic breast cancer [J].
Lorusso, V ;
Crucitta, E ;
Silvestris, N ;
Catino, A ;
Caporusso, L ;
Mazzei, A ;
Guida, M ;
Latorre, A ;
Sambiasi, D ;
D'Amico, C ;
Schittulli, F ;
Calabrese, P ;
De Lena, M .
BRITISH JOURNAL OF CANCER, 2003, 88 (04) :491-495
[32]   Phase I/II study of gemcitabine plus mitoxantrone as salvage chemotherapy in metastatic breast cancer [J].
V Lorusso ;
E Crucitta ;
N Silvestris ;
A Catino ;
L Caporusso ;
A Mazzei ;
M Guida ;
A Latorre ;
D Sambiasi ;
C D'Amico ;
F Schittulli ;
P Calabrese ;
M De Lena .
British Journal of Cancer, 2003, 88 :491-495
[33]   Paclitaxel and mitoxantrone in metastatic breast cancer: A phase II trial of the Italian Oncology Group for Cancer Research [J].
Di Costanzo, F ;
Manzione, L ;
Gasperoni, S ;
Bilancia, D ;
Acito, L ;
Angiona, S ;
Mazzoni, F ;
Giustini, L .
CANCER INVESTIGATION, 2004, 22 (03) :331-337
[34]   PHASE-II STUDY OF A NEW VINCA ALKALOID DERIVATIVE, S12363, IN ADVANCED BREAST-CANCER [J].
ADENIS, A ;
PION, JM ;
FUMOLEAU, P ;
POUILLART, P ;
MARTY, M ;
GIROUX, B ;
BONNETERRE, J .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1995, 35 (06) :527-528
[35]   PHASE-II STUDY OF PROTRACTED INFUSIONAL 5-FLUOROURACIL COMBINED WITH CISPLATINUM FOR ADVANCED GASTRIC-CANCER - REPORT FROM THE JAPAN CLINICAL ONCOLOGY GROUP (JCOG) [J].
OHTSU, A ;
SHIMADA, Y ;
YOSHIDA, S ;
SAITO, H ;
SEKI, S ;
MORISE, K ;
KURIHARA, M .
EUROPEAN JOURNAL OF CANCER, 1994, 30A (14) :2091-2093
[36]   PHASE-II TRIAL OF HIGH-DOSE EPIRUBICIN AND CYCLOPHOSPHAMIDE IN ADVANCED BREAST-CANCER [J].
SCINTO, AF ;
CERCATO, MC ;
BOTTI, C ;
TONACHELLA, R ;
FERRARESI, V ;
DELBIANCO, S ;
SACCHI, I ;
COGNETTI, F .
EUROPEAN JOURNAL OF CANCER, 1994, 30A (09) :1285-1288
[37]   PHASE-II TRIAL OF MITOXANTRONE IN ACUTE LYMPHOCYTIC-LEUKEMIA OF CHILDHOOD - A PEDIATRIC-ONCOLOGY-GROUP STUDY [J].
GRAHAM, ML ;
ESTRADA, J ;
RAGAB, AH ;
STARLING, KA ;
ROSEN, D ;
WILKERSON, RW .
INVESTIGATIONAL NEW DRUGS, 1991, 9 (03) :263-267
[38]   PHASE-II TRIAL OF CARBOPLATIN AND ETOPOSIDE ACTIVITY IN PRETREATED BREAST-CANCER PATIENTS [J].
VINOLAS, N ;
DANIELS, M ;
ESTAPE, J ;
GRAU, JJ ;
PALOMBO, H ;
SOLA, C .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1992, 15 (02) :160-162
[39]   VERAPAMIL WITH MITOXANTRONE FOR ADVANCED OVARIAN-CANCER - A NEGATIVE PHASE-II TRIAL [J].
HENDRICK, AM ;
HARRIS, AL ;
CANTWELL, BMJ .
ANNALS OF ONCOLOGY, 1991, 2 (01) :71-72
[40]   L-FOLINIC ACID AND 5-FLUOROURACIL IN THE TREATMENT OF ADVANCED BREAST-CANCER - A PHASE-II STUDY [J].
ZANIBONI, A ;
MERIGGI, F ;
ARCANGELI, G ;
MARPICATI, P ;
MONTINI, E ;
SIMONCINI, E ;
MARINI, G .
ANNALS OF ONCOLOGY, 1993, 4 :S41-S43
12345